世界のC型肝炎治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Hepatitis C Drugs Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2784 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、C型肝炎治療薬のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗ウイルス剤、免疫調節剤、その他）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・C型肝炎治療薬の市場動向 ・企業の競争状況、市場シェア ・C型肝炎治療薬の種類別市場規模（抗ウイルス剤、免疫調節剤、その他） ・C型肝炎治療薬の用途別市場規模（病院、クリニック） ・C型肝炎治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・C型肝炎治療薬のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・C型肝炎治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・C型肝炎治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・C型肝炎治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Gilead sciences、Abbvi、Johnson & Johnson、Merck、Glaxosmithkline、Novartis、Bristol-Myers Squibb、Roche） ・結論

Hepatitis is inflammation of the liver characterized by yellowed eyes and skin due to bilirubin, flu-like symptoms which include nausea, vomiting, poor appetite, joint pain, headaches, clay colored stools etc.
Hepatitis is caused by a variety of factors both microbial and non-microbial. However hepatitis C is caused by hepatitis C virus and affects between 130–150 million people globally every year of which approximately 700 000 people die from hepatitis C-related liver diseases. What is of greater concern is the fact that 15 to 20% of chronically infected patients develop liver cirrhosis or liver cancer.

Market Analysis and Insights: Global Hepatitis C Drugs Market
The global Hepatitis C Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hepatitis C Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hepatitis C Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hepatitis C Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hepatitis C Drugs market.

Global Hepatitis C Drugs Scope and Market Size
Hepatitis C Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hepatitis C Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Anti-Viral
Immuno-modulators
Others

Segment by Application
Hospitals
Clinics

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Gilead sciences
Abbvi
Johnson & Johnson
Merck
Glaxosmithkline
Novartis
Bristol-Myers Squibb
Roche

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hepatitis C Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Anti-Viral
1.2.3 Immuno-modulators
1.2.4 Others
1.3 Market by Application
1.3.1 Global Hepatitis C Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Hepatitis C Drugs Market Perspective (2016-2027)
2.2 Hepatitis C Drugs Growth Trends by Regions
2.2.1 Hepatitis C Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hepatitis C Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Hepatitis C Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Hepatitis C Drugs Industry Dynamic
2.3.1 Hepatitis C Drugs Market Trends
2.3.2 Hepatitis C Drugs Market Drivers
2.3.3 Hepatitis C Drugs Market Challenges
2.3.4 Hepatitis C Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Hepatitis C Drugs Players by Revenue
3.1.1 Global Top Hepatitis C Drugs Players by Revenue (2016-2021)
3.1.2 Global Hepatitis C Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Hepatitis C Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hepatitis C Drugs Revenue
3.4 Global Hepatitis C Drugs Market Concentration Ratio
3.4.1 Global Hepatitis C Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hepatitis C Drugs Revenue in 2020
3.5 Hepatitis C Drugs Key Players Head office and Area Served
3.6 Key Players Hepatitis C Drugs Product Solution and Service
3.7 Date of Enter into Hepatitis C Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Hepatitis C Drugs Breakdown Data by Type
4.1 Global Hepatitis C Drugs Historic Market Size by Type (2016-2021)
4.2 Global Hepatitis C Drugs Forecasted Market Size by Type (2022-2027)

5 Hepatitis C Drugs Breakdown Data by Application
5.1 Global Hepatitis C Drugs Historic Market Size by Application (2016-2021)
5.2 Global Hepatitis C Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Hepatitis C Drugs Market Size (2016-2027)
6.2 North America Hepatitis C Drugs Market Size by Type
6.2.1 North America Hepatitis C Drugs Market Size by Type (2016-2021)
6.2.2 North America Hepatitis C Drugs Market Size by Type (2022-2027)
6.2.3 North America Hepatitis C Drugs Market Size by Type (2016-2027)
6.3 North America Hepatitis C Drugs Market Size by Application
6.3.1 North America Hepatitis C Drugs Market Size by Application (2016-2021)
6.3.2 North America Hepatitis C Drugs Market Size by Application (2022-2027)
6.3.3 North America Hepatitis C Drugs Market Size by Application (2016-2027)
6.4 North America Hepatitis C Drugs Market Size by Country
6.4.1 North America Hepatitis C Drugs Market Size by Country (2016-2021)
6.4.2 North America Hepatitis C Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Hepatitis C Drugs Market Size (2016-2027)
7.2 Europe Hepatitis C Drugs Market Size by Type
7.2.1 Europe Hepatitis C Drugs Market Size by Type (2016-2021)
7.2.2 Europe Hepatitis C Drugs Market Size by Type (2022-2027)
7.2.3 Europe Hepatitis C Drugs Market Size by Type (2016-2027)
7.3 Europe Hepatitis C Drugs Market Size by Application
7.3.1 Europe Hepatitis C Drugs Market Size by Application (2016-2021)
7.3.2 Europe Hepatitis C Drugs Market Size by Application (2022-2027)
7.3.3 Europe Hepatitis C Drugs Market Size by Application (2016-2027)
7.4 Europe Hepatitis C Drugs Market Size by Country
7.4.1 Europe Hepatitis C Drugs Market Size by Country (2016-2021)
7.4.2 Europe Hepatitis C Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Hepatitis C Drugs Market Size (2016-2027)
8.2 Asia-Pacific Hepatitis C Drugs Market Size by Type
8.2.1 Asia-Pacific Hepatitis C Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hepatitis C Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hepatitis C Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Hepatitis C Drugs Market Size by Application
8.3.1 Asia-Pacific Hepatitis C Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hepatitis C Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hepatitis C Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Hepatitis C Drugs Market Size by Region
8.4.1 Asia-Pacific Hepatitis C Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hepatitis C Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Hepatitis C Drugs Market Size (2016-2027)
9.2 Latin America Hepatitis C Drugs Market Size by Type
9.2.1 Latin America Hepatitis C Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Hepatitis C Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Hepatitis C Drugs Market Size by Type (2016-2027)
9.3 Latin America Hepatitis C Drugs Market Size by Application
9.3.1 Latin America Hepatitis C Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Hepatitis C Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Hepatitis C Drugs Market Size by Application (2016-2027)
9.4 Latin America Hepatitis C Drugs Market Size by Country
9.4.1 Latin America Hepatitis C Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Hepatitis C Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Hepatitis C Drugs Market Size (2016-2027)
10.2 Middle East & Africa Hepatitis C Drugs Market Size by Type
10.2.1 Middle East & Africa Hepatitis C Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hepatitis C Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hepatitis C Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Hepatitis C Drugs Market Size by Application
10.3.1 Middle East & Africa Hepatitis C Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hepatitis C Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hepatitis C Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Hepatitis C Drugs Market Size by Country
10.4.1 Middle East & Africa Hepatitis C Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hepatitis C Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Gilead sciences
11.1.1 Gilead sciences Company Details
11.1.2 Gilead sciences Business Overview
11.1.3 Gilead sciences Hepatitis C Drugs Introduction
11.1.4 Gilead sciences Revenue in Hepatitis C Drugs Business (2016-2021)
11.1.5 Gilead sciences Recent Development
11.2 Abbvi
11.2.1 Abbvi Company Details
11.2.2 Abbvi Business Overview
11.2.3 Abbvi Hepatitis C Drugs Introduction
11.2.4 Abbvi Revenue in Hepatitis C Drugs Business (2016-2021)
11.2.5 Abbvi Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Hepatitis C Drugs Introduction
11.3.4 Johnson & Johnson Revenue in Hepatitis C Drugs Business (2016-2021)
11.3.5 Johnson & Johnson Recent Development
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck Hepatitis C Drugs Introduction
11.4.4 Merck Revenue in Hepatitis C Drugs Business (2016-2021)
11.4.5 Merck Recent Development
11.5 Glaxosmithkline
11.5.1 Glaxosmithkline Company Details
11.5.2 Glaxosmithkline Business Overview
11.5.3 Glaxosmithkline Hepatitis C Drugs Introduction
11.5.4 Glaxosmithkline Revenue in Hepatitis C Drugs Business (2016-2021)
11.5.5 Glaxosmithkline Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Hepatitis C Drugs Introduction
11.6.4 Novartis Revenue in Hepatitis C Drugs Business (2016-2021)
11.6.5 Novartis Recent Development
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Details
11.7.2 Bristol-Myers Squibb Business Overview
11.7.3 Bristol-Myers Squibb Hepatitis C Drugs Introduction
11.7.4 Bristol-Myers Squibb Revenue in Hepatitis C Drugs Business (2016-2021)
11.7.5 Bristol-Myers Squibb Recent Development
11.8 Roche
11.8.1 Roche Company Details
11.8.2 Roche Business Overview
11.8.3 Roche Hepatitis C Drugs Introduction
11.8.4 Roche Revenue in Hepatitis C Drugs Business (2016-2021)
11.8.5 Roche Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Hepatitis C Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Anti-Viral
Table 3. Key Players of Immuno-modulators
Table 4. Key Players of Others
Table 5. Global Hepatitis C Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Hepatitis C Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Hepatitis C Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Hepatitis C Drugs Market Share by Regions (2016-2021)
Table 9. Global Hepatitis C Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Hepatitis C Drugs Market Share by Regions (2022-2027)
Table 11. Hepatitis C Drugs Market Trends
Table 12. Hepatitis C Drugs Market Drivers
Table 13. Hepatitis C Drugs Market Challenges
Table 14. Hepatitis C Drugs Market Restraints
Table 15. Global Hepatitis C Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Hepatitis C Drugs Market Share by Players (2016-2021)
Table 17. Global Top Hepatitis C Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis C Drugs as of 2020)
Table 18. Ranking of Global Top Hepatitis C Drugs Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Hepatitis C Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Hepatitis C Drugs Product Solution and Service
Table 22. Date of Enter into Hepatitis C Drugs Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Hepatitis C Drugs Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Hepatitis C Drugs Revenue Market Share by Type (2016-2021)
Table 26. Global Hepatitis C Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Hepatitis C Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Hepatitis C Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Hepatitis C Drugs Revenue Market Share by Application (2016-2021)
Table 30. Global Hepatitis C Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Hepatitis C Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Hepatitis C Drugs Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Hepatitis C Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Hepatitis C Drugs Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Hepatitis C Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Hepatitis C Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Hepatitis C Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Hepatitis C Drugs Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Hepatitis C Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Hepatitis C Drugs Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Hepatitis C Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Hepatitis C Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Hepatitis C Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Hepatitis C Drugs Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Hepatitis C Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Hepatitis C Drugs Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Hepatitis C Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Hepatitis C Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Hepatitis C Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Hepatitis C Drugs Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Hepatitis C Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Hepatitis C Drugs Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Hepatitis C Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Hepatitis C Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Hepatitis C Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Hepatitis C Drugs Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Hepatitis C Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Hepatitis C Drugs Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Hepatitis C Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Hepatitis C Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Hepatitis C Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 62. Gilead sciences Company Details
Table 63. Gilead sciences Business Overview
Table 64. Gilead sciences Hepatitis C Drugs Product
Table 65. Gilead sciences Revenue in Hepatitis C Drugs Business (2016-2021) & (US$ Million)
Table 66. Gilead sciences Recent Development
Table 67. Abbvi Company Details
Table 68. Abbvi Business Overview
Table 69. Abbvi Hepatitis C Drugs Product
Table 70. Abbvi Revenue in Hepatitis C Drugs Business (2016-2021) & (US$ Million)
Table 71. Abbvi Recent Development
Table 72. Johnson & Johnson Company Details
Table 73. Johnson & Johnson Business Overview
Table 74. Johnson & Johnson Hepatitis C Drugs Product
Table 75. Johnson & Johnson Revenue in Hepatitis C Drugs Business (2016-2021) & (US$ Million)
Table 76. Johnson & Johnson Recent Development
Table 77. Merck Company Details
Table 78. Merck Business Overview
Table 79. Merck Hepatitis C Drugs Product
Table 80. Merck Revenue in Hepatitis C Drugs Business (2016-2021) & (US$ Million)
Table 81. Merck Recent Development
Table 82. Glaxosmithkline Company Details
Table 83. Glaxosmithkline Business Overview
Table 84. Glaxosmithkline Hepatitis C Drugs Product
Table 85. Glaxosmithkline Revenue in Hepatitis C Drugs Business (2016-2021) & (US$ Million)
Table 86. Glaxosmithkline Recent Development
Table 87. Novartis Company Details
Table 88. Novartis Business Overview
Table 89. Novartis Hepatitis C Drugs Product
Table 90. Novartis Revenue in Hepatitis C Drugs Business (2016-2021) & (US$ Million)
Table 91. Novartis Recent Development
Table 92. Bristol-Myers Squibb Company Details
Table 93. Bristol-Myers Squibb Business Overview
Table 94. Bristol-Myers Squibb Hepatitis C Drugs Product
Table 95. Bristol-Myers Squibb Revenue in Hepatitis C Drugs Business (2016-2021) & (US$ Million)
Table 96. Bristol-Myers Squibb Recent Development
Table 97. Roche Company Details
Table 98. Roche Business Overview
Table 99. Roche Revenue in Hepatitis C Drugs Business (2016-2021) & (US$ Million)
Table 100. Roche Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hepatitis C Drugs Market Share by Type: 2020 VS 2027
Figure 2. Anti-Viral Features
Figure 3. Immuno-modulators Features
Figure 4. Others Features
Figure 5. Global Hepatitis C Drugs Market Share by Application: 2020 VS 2027
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Hepatitis C Drugs Report Years Considered
Figure 9. Global Hepatitis C Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Hepatitis C Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Hepatitis C Drugs Market Share by Regions: 2020 VS 2027
Figure 12. Global Hepatitis C Drugs Market Share by Regions (2022-2027)
Figure 13. Global Hepatitis C Drugs Market Share by Players in 2020
Figure 14. Global Top Hepatitis C Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hepatitis C Drugs as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Hepatitis C Drugs Revenue in 2020
Figure 16. Global Hepatitis C Drugs Revenue Market Share by Type (2016-2021)
Figure 17. Global Hepatitis C Drugs Revenue Market Share by Type (2022-2027)
Figure 18. North America Hepatitis C Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Hepatitis C Drugs Market Share by Type (2016-2027)
Figure 20. North America Hepatitis C Drugs Market Share by Application (2016-2027)
Figure 21. North America Hepatitis C Drugs Market Share by Country (2016-2027)
Figure 22. United States Hepatitis C Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Hepatitis C Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Hepatitis C Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Hepatitis C Drugs Market Share by Type (2016-2027)
Figure 26. Europe Hepatitis C Drugs Market Share by Application (2016-2027)
Figure 27. Europe Hepatitis C Drugs Market Share by Country (2016-2027)
Figure 28. Germany Hepatitis C Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Hepatitis C Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Hepatitis C Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Hepatitis C Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Hepatitis C Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Hepatitis C Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Hepatitis C Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Hepatitis C Drugs Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Hepatitis C Drugs Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Hepatitis C Drugs Market Share by Region (2016-2027)
Figure 38. China Hepatitis C Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Hepatitis C Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Hepatitis C Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Hepatitis C Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Hepatitis C Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Hepatitis C Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Hepatitis C Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Hepatitis C Drugs Market Share by Type (2016-2027)
Figure 46. Latin America Hepatitis C Drugs Market Share by Application (2016-2027)
Figure 47. Latin America Hepatitis C Drugs Market Share by Country (2016-2027)
Figure 48. Mexico Hepatitis C Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Hepatitis C Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Hepatitis C Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Hepatitis C Drugs Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Hepatitis C Drugs Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Hepatitis C Drugs Market Share by Country (2016-2027)
Figure 54. Turkey Hepatitis C Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Hepatitis C Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Hepatitis C Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Gilead sciences Revenue Growth Rate in Hepatitis C Drugs Business (2016-2021)
Figure 58. Abbvi Revenue Growth Rate in Hepatitis C Drugs Business (2016-2021)
Figure 59. Johnson & Johnson Revenue Growth Rate in Hepatitis C Drugs Business (2016-2021)
Figure 60. Merck Revenue Growth Rate in Hepatitis C Drugs Business (2016-2021)
Figure 61. Glaxosmithkline Revenue Growth Rate in Hepatitis C Drugs Business (2016-2021)
Figure 62. Novartis Revenue Growth Rate in Hepatitis C Drugs Business (2016-2021)
Figure 63. Bristol-Myers Squibb Revenue Growth Rate in Hepatitis C Drugs Business (2016-2021)
Figure 64. Roche Revenue Growth Rate in Hepatitis C Drugs Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

---